{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-012106","form_type":"8-K","ticker":"CAPR","cik":"0001133869","company_name":"CAPRICOR THERAPEUTICS, INC.","filed_at":"2023-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.215377+00:00","generated_at":"2026-06-13T04:01:52.410573+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Capricor expands board to 8, appoints former Novartis BD executive Philip Gotwals","bullets":["Board increased from 7 to 8 directors; Philip Gotwals, Ph.D. elected effective July 21, 2023.","Gotwals brings nearly 30 years biotech experience, most recently Global Head of BD at Novartis.","Received initial grant of nonstatutory stock option to purchase 115,000 shares, vesting over 4 years.","Will not initially serve on any committee; standard indemnification agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-012106","json":"https://secwatch.observer/filing/0001558370-23-012106.json","markdown":"https://secwatch.observer/filing/0001558370-23-012106.md","text":"https://secwatch.observer/filing/0001558370-23-012106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133869/000155837023012106/0001558370-23-012106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133869/000155837023012106/capr-20230721x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T04:01:52.410573+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ca5df5636","claim":"Philip Gotwals was elected as Director at CAPRICOR THERAPEUTICS, INC..","evidence_excerpt":"approved an increase of the size of the Board from seven to eight directors, and elected Philip Gotwals, Ph.D. as a member of the Board to fill the newly created vacancy, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133869/000155837023012106/0001558370-23-012106-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}